*Escherichia coli* O157 is recognized worldwide as an important cause of diarrheal disease, which in some patients is followed by hemolytic uremic syndrome and death ([@R1]). A primary virulence factor of this pathogen is the prophage-encoded Shiga toxin ([@R2]). Greater Shiga toxin production per bacterium is associated with increasing severity of human disease ([@R3],[@R4]). Because of its location in the phage genome, the *stx*-gene variant dubbed *stx*~2~ is under similar regulatory control as other phage late-genes, as it is governed by the interaction of the transcription antiterminator Q with the late promoter P~R~´ ([@R5]).

Although cattle and other ruminants appear to be the natural reservoir for *E. coli* O157 and other Shiga toxin--producing *E. coli* (STEC), only a small fraction of STEC serotypes routinely present in cattle are frequently isolated from human patients. Mounting evidence suggests that considerable genetic, phenotypic, and pathogenic diversity exists among these pathogens ([@R6]--[@R8]). Furthermore, genetic subtypes or lineages of *E. coli* O157 do not appear to be equally distributed among isolates of bovine and human origin ([@R7]). The purpose of this study was to examine the distribution of specific sequences upstream of the *stx*~2~ gene among *E. coli* O157:H7 of human and bovine origin, along with corresponding magnitudes of Shiga toxin production.

The Study
=========

A total of 158 *stx*~2~-encoding *E. coli* O157:H7 isolates were assayed, 91 isolates of bovine origin and 67 originally isolated from ill persons ([Tables A1](#TA.1){ref-type="table"} and [A2](#TA.2){ref-type="table"}). All isolates demonstrated unique banding patterns on pulsed-field gel electrophoresis (PFGE). For polymerase chain reaction (PCR) analysis, 5 µL of DNA obtained from boiled stationary-phase bacteria was added to a 50-µL PCR master mix containing a final concentration of 1.5 (*Q*~933~) or 2.5 (*Q*~21~) mmol MgCl~2~, 200 µmol/L each deoxynucleoside triphosphate, 1 U *Taq* polymerase, 0.6 pg/µL of primer 595 (5´-CCGAAGAAAAACCCAGTAACAG-3´) ([@R9]), and 0.6 pg/µL of either primer *Q*~933~ (5´-CGGAGGGGATTGTTGAAGGC-3´;Q~Stxf~) ([@R9]) or primer *Q*~21~ (5´-GAAATCCTCAATGCCTCGTTG-3´; this study). PCR consisted of an initial denaturation at 94°C for 5 min; 30 cycles of 94°C for 30 s, 52°C (*Q*~933~) or 55°C (*Q*~21~) for 1 min, and 72°C for 1 min; and a final 10-min extension step at 72°C. *E. coli* strain 933 or FAHRP88 was used as a positive control and master mix alone as a negative control. All PCR products were separated by gel electrophoresis (100 V) in 1% agarose gels, stained with ethidium bromide, and visualized by using UV illumination.

Shiga toxin production was determined by using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Premiere EHEC, Meridian Diagnostics, Cincinnati, OH). Briefly, log-phase cells from Luria-Bertani broth enrichments were diluted to 0.6 optical density (OD) at 600 nm, subsequently pelleted, resuspended in phosphate-buffered saline, and induced by exposure to UV light (240 nm) for 3 s ([@R10]). A 1:9 volume of a 10x concentrate of brain heart infusion broth was added to each culture and shaken at 37°C for 2.5 h. Replicate cultures that were not exposed to UV light (noninduced controls) were maintained at 4°C. Two hundred microliters of each induced and noninduced enrichment was subsequently used as the specimen in the EHEC ELISA, as described ([@R11]). OD results were recorded for each isolate both with and without UV induction. The relative change in Shiga toxin production after induction was calculated for each isolate; (OD~induced~)/OD~noninduced~). *E. coli* O157 (EDL933) and a toxin-negative control isolate were assayed as positive and negative controls each time the assay was repeated.

*E. coli* O157 isolates were classified on the basis of the presence or absence of bands of the predicted size on the *Q*~933~-595 and *Q*~21~-595 PCR reactions ([Figure](#F1){ref-type="fig"}). A chi-square test was used to determine whether different PCR genotypes were equally distributed among isolates of bovine and human origin. Likewise, a chi-square test was used to assess the equality of distribution of PCR genotypes among bovine isolates from different countries. One-way analysis of variance for nonparametric data (Kruskal-Wallis test) was used to identify differences in ranked-transformed toxin production among noninduced and induced *E. coli* O157 isolates as well as to determine significant differences in the percent increase in toxin following induction.
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Previously, Kim et al. described a nonrandom distribution of *E. coli* O157 subtypes among cattle and humans by using an octamer-based genome-scanning method ([@R7]). We tested several of the isolates that had been previously characterized. Nine had been previously identified as belonging to the lineage I genotype and seven isolates as belonging to the lineage II genotype. We found that all nine lineage I isolates consistently amplified the *Q*~933~ target, regardless of species of origin. All four bovine isolates classified as lineage II by Kim et al. amplified the *Q*~21~ target. One lineage II human isolate (NE015) amplified the *Q*~933~ target, and another lineage II isolate (NE037) produced no amplicons in either PCR reaction. One human isolate classified as lineage II (ATCC 43889) amplified both target sequences, presumably because of polylysogeny.

The distribution of the specific *Q*-gene alleles found upstream of the prophage *stx* region among bovine isolates may have a geographic component. The distribution of *E. coli* O157 phage genotypes collected from healthy cattle from diverse geographic areas is consistent with the variable incidences of human disease in different countries ([Table 1](#T1){ref-type="table"}). For example, six (75%) of eight Scottish bovine isolates examined amplified the *Q*~933~ target, the same target that is frequently present in human isolates of human disease origin. Scotland reports some of the highest incidence rates of human *E. coli* O157--related diseases and hemolytic uremic syndrome ([@R13]). In contrast, none of the seven Australian *E. coli* O157 bovine isolates amplified the 1750-bp fragment. Contrary to the situation in Scotland and the United States, *E. coli* O157 infection of humans is rarely reported in Australia ([@R14]).

###### Distribution of polymerase chain reaction results from bovine *Escherichia coli* O157 isolates based on geographic origin^a^

  Country of origin   No. tested   *Q* allele             
  ------------------- ------------ ------------ --------- --------
  USA                 46           20 (44)      25 (54)   1 (2)
  Scotland            8            -- (0)       2 (25)    6 (75)
  Australia           7            -- (0)       7 (100)   -- (0)
  Japan               17           3 (18)       14 (82)   -- (0)
  Total               78           23 (29)      48 (62)   7 (9)

^a^--, not detected. Percentages are read across rows, not down columns. Significant difference in proportion of *Q* alleles isolated from different countries (p \< 0.05, chi-square test for homogeneity).

Conclusions
===========

The *Q*~933~ gene target was more commonly identified in human disease--associated strains of *E. coli* O157 than from strains of bovine origin. Amplification of the *Q*~933~ target, either alone or in combination with amplification of the *Q*~21~ target from the same isolate, was identified in 60 (9%) of 66 (55/66 alone and 5/66 in combination with *Q*~21~; 1 isolate amplified neither target) compared to 40 (44%) of 91 (32/91 alone, and 8/91 in combination with *Q*~21~) of bovine isolates (p \< 0.001). Furthermore, these genetic subtypes were nonrandomly distributed among the *E. coli* O157 isolates of bovine origin obtained from different countries (p \< 0.05) ([Table 1](#T1){ref-type="table"}).

These limited data suggest that the distribution of *E. coli* O157 strains in cattle may differ between countries or regions, thereby providing an explanation for geographic differences in the incidence of human *E. coli* O157 infection. More isolates from cattle need to be analyzed with these methods to better characterize the *E. coli* O157 in the bovine reservoir of each country.

A positive reaction with the *Q*~933~ target was significantly associated with higher OD results on the Shiga toxin ELISA (both noninduced and induced) and higher-fold increases in toxin production following induction than isolates amplifying the *Q*~21~ target alone (p \< 0.0001) ([Table 2](#T2){ref-type="table"}). Despite these differences, we did not identify any clinical associations between the magnitude of Shiga toxin production and severity of human disease could be identified in this study. Other, non--Shiga toxin--related virulence factors and host susceptibility are also believed to play essential roles in the outcome of clinical STEC infections. The *Q*~933~-negative isolates obtained from human disease might have lost this *Q*~933~-containing prophage by the time of isolation, or these isolates might have been recovered from patients also infected with STEC containing *Q*~933~-type prophage ([@R15]). Whether specific *Q*-gene alleles directly correlate with the magnitude of Shiga-toxin production or whether other (unstudied) factors within the phage lytic cascade genetically linked to specific *Q* alleles instead are responsible for the magnitude of toxin production is not known.

###### Shiga toxin production by *Escherichia coli* O157:H7 by *Q* allele

  ----------------------------------------------- ------------ ---------- ------- -------
  Assay                                           *Q* allele   Response           
  Median                                          Minimum      Maximum            
  OD~600nm~ noninduced                            *Q*~933~     0.442      0.153   2.814
                                                  *Q*~21~      0.170      0.120   0.413
  OD~600nm~ induced                               *Q*~933~     1.228      0.172   2.896
                                                  *Q*~21~      0.165      0.084   1.210
  Fold increase in OD~600nm~ after induction^a^   *Q*~933~     2.2        0.3     7.7
  *Q*~21~                                         0.9          0.4        5.1     
  ----------------------------------------------- ------------ ---------- ------- -------

^a^(OD~induced~)/(OD~noninduced~). The maximum and minimum optical density readings at 600 nm listed in each row are not necessarily from the same isolate; therefore, the maximum- and minimum-fold increase cannot be calculated directly from the table.

The antiterminator Q, the protein product of the *Q* gene, and *P*~R´~, the late promoter, are reputed to be involved in regulating phage late-genes and, because of the location of *P*~R´~ in prophage genome, of Shiga toxin production as well ([@R5]). In *E. coli* O157 phage 933W (GenBank no. 9632466) and *E. coli* O157 *stx~2vhd~* (GenBank no. 15718404), the 359-bp sequence immediately upstream of the *stx~2~* gene is nearly identical (\>95% nucleotide identity). However, further upstream of this area of identity, DNA sequences differ significantly. In *E. coli* O157 933W, this gene is identified as the antiterminator *Q* gene. In contrast, in *E. coli* O157 *stx~2vhd~* this area is occupied by a gene with \>95% sequence identity with the antiterminator *Q* gene of bacteriophage 21 (gi 4539472). The *Q* gene of bacteriophage 21 does not share DNA sequence homology with the *Q* gene of bacteriophage 933W, and only 36% predicted amino acid homology. Since the *Q* gene is reputed to play an important role in regulating toxin production, our results provide a plausible explanation (differential regulation of Shiga toxin production) of why certain *E. coli* O157 genotypes are more commonly isolated from human patients ([@R7]).

*Suggested citation for this article*: LeJeune JT, Abedon ST, Takemura K, Christie NP, Sreevatsan S. Human *Escherichia coli* O157:H7 genetic marker in isolates of bovine origin. Emerg Infect Dis \[serial on the Internet\]. 2004 Aug \[*date cited*\]. <http://dx.doi.org/10.3201/eid1008.030784>

We thank the state departments of health of Ohio, Washington, and Idaho for many of the human isolates used in this study and the SETC Center, Michigan State University, for providing two of the strains we tested.

This project was funded by beef and veal producers and importers through their \$1-per-head checkoff and was produced for the Cattlemen\'s Beef Board and state beef councils by the National Cattlemen\'s Beef Association. Research in S.S. and J.T.L. laboratories is also supported by state and federal funds appropriated to the Ohio Agricultural Research and Development Center.

###### Source of human isolates used in this study^a^

  FAHRP ID   Source ID    Country   Year   Clinical signs and symptoms   References or source
  ---------- ------------ --------- ------ ----------------------------- ----------------------
  6          FRIK 528     USA       1998   Diarrhea                      16
  7          FRIK 579     USA       1998   Diarrhea                      16
  8          93-001       USA       1999   Hemorrhagic colitis           17
  9          ATCC 35150   USA       1999   Hemorrhagic colitis           17
  16         91671        USA       1999   Hemorrhagic colitis           17
  17         ATCC 43889   USA       1999   Hemorrhagic colitis           17
  18         NE 037       USA       1999   Hemorrhagic colitis           17
  19         NE 15        USA       1999   Hemorrhagic colitis           17
  39         E29962       UK        1991   NR                            18
  54         CL56         Canada    1991   NR                            18
  60         E32511       USA       2002   HUS                           19
  58         EDL933       USA       1982   Hemorrhagic colitis           20
  126        02 5225      USA       2002   NR                            Washington^b^
  127        02 4857      USA       2002   NR                            Washington
  128        02 6776      USA       2002   NR                            Washington
  129        02 6579      USA       2002   NR                            Washington
  130        02 6546      USA       2002   NR                            Washington
  131        02 6722      USA       2002   NR                            Washington
  132        02 6598      USA       2002   NR                            Washington
  133        02 6696      USA       2002   NR                            Washington
  134        02 6791      USA       2002   NR                            Washington
  135        02 6829      USA       2002   NR                            Washington
  136        02 6755      USA       2002   NR                            Washington
  137        02 6644      USA       2002   NR                            Washington
  138        06 781       USA       2002   Diarrhea                      Idaho^c^
  139        06 852       USA       2002   NR                            Idaho
  140        06 854       USA       2002   Watery diarrhea, vomiting     Idaho
  141        06 856       USA       2002   Diarrhea                      Idaho
  142        06 855       USA       2002   NR                            
  143        06 886       USA       2002   Diarrhea, abdominal pain      Idaho
  144        06 889       USA       2002   Abdominal pain                Idaho
  145        06 988       USA       2002   Gastrointestinal bleeding     Idaho
  146        07 004       USA       2002   Bloody stool                  Idaho
  147        07 007       USA       2002   Bloody stool                  Idaho
  148        07 023       USA       2002   Bloody stool                  Idaho
  149        07 085       USA       2002   NR                            Idaho
  150        07 147       USA       2002   NR                            Idaho
  151        07 154       USA       2002   NR                            Idaho
  152        O2191230     USA       2002   Diarrhea                      Ohio^d^
  153        O2191229     USA       2002   Diarrhea                      Ohio
  154        O2191231     USA       2002   Diarrhea                      Ohio
  155        O2191294     USA       2002   Diarrhea                      Ohio
  156        O2190819     USA       2002   Diarrhea                      Ohio
  157        O2190864     USA       2002   Diarrhea                      Ohio
  158        O2191309     USA       2002   Diarrhea                      Ohio
  159        O2191311     USA       2002   Diarrhea                      Ohio
  160        O2191313     USA       2002   Diarrhea                      Ohio
  161        O2191361     USA       2002   Diarrhea                      Ohio
  162        O2191602     USA       2002   Diarrhea                      Ohio
  163        O2191624     USA       2002   Diarrhea                      Ohio
  164        O2191541     USA       2002   Diarrhea                      Ohio
  165        O2191546     USA       2002   Diarrhea                      Ohio
  166        O2191423     USA       2002   Diarrhea                      Ohio
  167        O2191509     USA       2002   Diarrhea                      Ohio
  168        O2191363     USA       2002   Diarrhea                      Ohio
  169        O2191364     USA       2002   Diarrhea                      Ohio
  170        O2191365     USA       2002   Diarrhea                      Ohio
  171        O2191366     USA       2002   Diarrhea                      Ohio
  172        O2190889     USA       2002   Diarrhea                      Ohio
  173        O2190893     USA       2002   Diarrhea                      Ohio
  174        O2191176     USA       2002   Diarrhea                      Ohio
  175        O2191177     USA       2002   Diarrhea                      Ohio
  176        O2191623     USA       2002   Diarrhea                      Ohio
  177        O2191625     USA       2002   Diarrhea                      Ohio
  178        O2191645     USA       2002   Diarrhea                      Ohio
  179        O2191675     USA       2002   Diarrhea                      Ohio
  180        O2191765     USA       2002   Diarrhea                      Ohio
  181        O2191831     USA       2002   Diarrhea                      Ohio

^a^FAHRP, Food Animal Health Research Program, Ohio State University; NR, not reported; HUS, hemolytic uremic syndrome. ^b^Washington State Department of Health isolates. ^c^Idaho Department of Health and Welfare isolates. ^d^Ohio Department of Health isolates.

###### Source of bovine isolates used in this study

  FAHRP^a^ ID   Source ID         Country     Year   References or source
  ------------- ----------------- ----------- ------ ----------------------
  1             FRIK 1986         USA         1991   21
  2             FRIK 1997         USA         1991   21
  3             FRIK 1994         USA         1991   21
  4             FRIK 2002         USA         1991   21
  5             FRIK 1987         USA         1991   21
  10            FRIK 920          USA         1998   22
  11            FRIK 1054         USA         1998   22
  12            FRIK 1540         USA         1998   22
  13            FRIK 1988         USA         1998   21
  22            LCDC 87-2930      Canada      1991   23
  27            OARDC1            USA         2002   FAHRP
  29            OARDC2            USA         2002   FAHRP
  31            OARDC3            USA         2002   FAHRP
  35            P673              UK          1987   24
  37            P277              UK          1987   24
  47            c1526-77          Argentina   1991   23
  50            CDC B9253-DMS1    USA         1991   23
  51            A39               Canada      1991   23
  52            A43               Canada      1991   23
  56            LCDC 87-2924      Canada      1991   23
  57            LCDC 87-1799      Canada      1991   23
  62            CDC B6830-MS1/0   USA         1991   23
  63            CDCB7205-MS1/0    USA         1991   23
  64            CDC B8038-MS1/0   USA         1991   23
  65            8832              USA         2002   25
  66            EC66              USA         2002   FAHRP
  67            EC 67             USA         2002   FAHRP
  82            8833              USA         2002   25
  83            EC 83             USA         2002   FAHRP
  84            EC 84             USA         2002   FAHRP
  85            8834              USA         2002   25
  87            EC87              USA         2002   FAHRP
  88            EC88              USA         2002   FAHRP
  93            EC 93             USA         2002   FAHRP
  94            EC94              USA         2002   FAHRP
  95            EC95              USA         2002   FAHRP
  96            EC96              USA         2002   FAHRP
  97            EC97              USA         2002   FAHRP
  98            EC98              USA         2002   FAHRP
  99            EC99              USA         2002   FAHRP
  100           EC100             USA         2002   FAHRP
  102           EC102             USA         2002   FAHRP
  103           EC103             USA         2002   FAHRP
  104           EC104             USA         2002   FAHRP
  113           8837              USA         2002   25
  115           EC115             USA         2002   FAHRP
  116           EC116             USA         2002   FAHRP
  117           EC117             USA         2002   FAHRP
  120           EC120             USA         2002   FAHRP
  122           EC122             USA         2002   FAHRP
  182           757               USA         1994   25
  183           817               USA         1994   25
  185           1104              USA         1994   25
  186           1119              USA         1994   25
  187           1124              USA         1994   25
  188           1136              USA         1994   25
  189           1273              USA         1994   25
  190           3735              USA         1996   25
  191           4048              USA         1996   25
  192           7407              Japan       1996   25
  193           7409              Japan       1996   25
  194           7416              Japan       1996   25
  195           7420              Japan       1996   25
  196           7421              Japan       1996   25
  197           7423              Japan       1996   25
  198           7433              Japan       1996   25
  199           7436              Japan       1996   25
  200           7439              Japan       1996   25
  201           7460              Japan       1996   25
  202           7469              Japan       1996   25
  203           7478              Japan       1996   25
  204           7484              Japan       1996   25
  205           7488              Japan       1996   25
  206           7495              Japan       1996   25
  207           7500              Japan       1996   25
  208           7505              Japan       1996   25
  209           7622              Scotland    1996   25
  210           7630              Scotland    1999   25
  211           7632              Scotland    1999   25
  213           7637              Scotland    1999   25
  214           7638              Scotland    1999   25
  217           7648              Scotland    1999   25
  218           7649              Scotland    1999   25
  219           7653              Scotland    1999   25
  220           8176              Australia   1999   25
  221           8177              Australia   1996   25
  222           8179              Australia   1997   25
  223           8182              Australia   1997   25
  224           8183              Australia   1997   25
  225           8184              Australia   1998   25
  226           8185              Australia   1999   25

^a^FAHRP, Food Animal Health Research Program, Ohio State University.
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